STOCK TITAN

Guardian Pharmacy VP David Norman Martin sells 5K shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4/A

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. (GRDN) reports that its Senior Vice President, Technology, Data & Senior Security Officer, David Norman Martin, sold 4,800 Class A shares at a weighted average price of $50.24 and 200 shares at a weighted average price of $50.58 on November 17, 2026. Both sales were made under a Rule 10b5-1(c) trading plan adopted August 18, 2026.

Insider Martin David Norman
Role See Remarks
Sold 5,000 shs ($251K)
Type Security Shares Price Value
Sale Class A Common Stock F1, F2 4,800 $50.24 $241K
Sale Class A Common Stock F1, F3 200 $50.58 $10K
Holdings After Transaction: Class A Common Stock — 135,905 shares (Direct)
Footnotes (3)
  1. F1. This Form 4/A is being filed to check the box to indicate that the transactions reported herein were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 18, 2026.
  2. F2. The price reported in Column 4 is a weighted average price. These shares of Class A common stock, par value $0.001 per share ("Common Stock"), of Guardian Pharmacy Services, Inc. (the "Issuer") were sold in multiple transactions at prices ranging from $49.57 to $50.56, inclusive. The reporting persons undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in Footnote 2 to this Form 4.
  3. F3. The price reported in Column 4 is a weighted average price. These shares of Common Stock of the Issuer were sold in multiple transactions at prices ranging from $50.57 to $50.59, inclusive. The reporting persons undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in Footnote 3 to this Form 4.
Class A shares sold 4,800 shares Sale on November 17, 2026
Weighted average sale price $50.24 per share 4,800-share sale on November 17, 2026
Class A shares sold 200 shares Sale on November 17, 2026
Weighted average sale price $50.58 per share 200-share sale on November 17, 2026
Rule 10b5-1(c) trading plan regulatory
"pursuant to a Rule 10b5-1(c) trading plan"
A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GRDN shares did David Norman Martin sell, and at what prices?

David Norman Martin sold 4,800 Class A shares at a weighted average price of $50.24 and 200 shares at a weighted average price of $50.58 on November 17, 2026. Both sales were made under a Rule 10b5-1(c) trading plan adopted August 18, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Martin David Norman

(Last)(First)(Middle)
300 GALLERIA PARKWAY SE, SUITE 800

(Street)
ATLANTA GEORGIA 30339

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
11/18/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/17/2026S(1)4,800D$50.24(2)136,105D
Class A Common Stock11/17/2026S(1)200D$50.58(3)135,905D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This Form 4/A is being filed to check the box to indicate that the transactions reported herein were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 18, 2026.
2. The price reported in Column 4 is a weighted average price. These shares of Class A common stock, par value $0.001 per share ("Common Stock"), of Guardian Pharmacy Services, Inc. (the "Issuer") were sold in multiple transactions at prices ranging from $49.57 to $50.56, inclusive. The reporting persons undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in Footnote 2 to this Form 4.
3. The price reported in Column 4 is a weighted average price. These shares of Common Stock of the Issuer were sold in multiple transactions at prices ranging from $50.57 to $50.59, inclusive. The reporting persons undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in Footnote 3 to this Form 4.
Remarks:
Senior Vice President, Technology, Data & Senior Security Officer
/s/ Douglas Towns, Attorney-in-Fact11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading